NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Patient-Derived Xenografts to Reduce Cancer Health Disparities

RecruitingN/A

Sponsor: University of California, Davis

Conditions: Bladder Carcinoma, Gastric Carcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Lung Carcinoma, Malignant Neoplasm

Interventions: Biospecimen Collection

Countries: United States

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

Eligibility overview

Sex: ALL

Age: 21 Years to 100 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer)
* Signed informed consent that will be put on file

Exclusion Criteria:

* No informed consent obtained
* Specimen unacceptable/degraded/etc.
* Individuals who are not yet adults (infants, children, teenagers)
* Pregnant women
* Prisoners
* Adults unable to consent

Locations (2)

Orange, California, United States
Sacramento, California, United States